GLUE 10-Q: SEC filing
Monte Rosa Therapeutics
Filed with the SEC on · accession 0001193125-26-448568
GLUE filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -5.3% by the first close after the filing.
Summary of the filing
Monte Rosa Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing ongoing collaboration and license agreements, including with Novartis and Roche, along with an at-the-market offering program.
Key details
How GLUE stock reacted
Close before
$10.82
Nov 4, 2026
First close after
-5.27%
$10.25
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for GLUE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for GLUE?
Click hereFrequently asked questions
What did GLUE file with the SEC on Nov 5, 2026?
GLUE filed a 10-Q (SEC filing). Monte Rosa Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing ongoing collaboration and license agreements, including with Novartis and Roche, along with an at-the-market offering program.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did GLUE stock react to this filing?
GLUE closed at $10.82 before the filing and $10.25 on Nov 5, 2026 (-5.27%).
Other GLUE SEC filings
Get alerts when GLUE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days